Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
PURPOSE: Various studies have examined the association between serum vitamin D levels and different cancers; however, this is the first prospective study of this association with melanoma risk. The aim of this study is to investigate the association between serum vitamin D [25(OH)D] levels and melanoma in a cohort of older, middle-aged Finnish male smokers. METHODS: We conducted a nested case-control study within the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study. From the ATBC cohort, 368 subjects were chosen for our study; 92 participants that developed melanoma and 276 matched control subjects. At study baseline, lifestyle questionnaires and blood samples were collected. Serum 25(OH)D was modeled as three sets of categorical variables: clinically-defined categories, season-specific quartiles and season-adjusted residual quartiles. Conditional logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (95% CIs) to estimate the association between circulating vitamin D and melanoma risk. RESULTS: Overall no association of serum 25(OH)D and melanoma risk was observed. A decreased risk of developing melanoma was observed in the middle categories compared to the lowest category, albeit not significant. CONCLUSION: Results indicate no association between serum 25(OH)D levels and melanoma. Additional studies, including possibly consortium efforts, are needed to investigate the association between serum 25(OH)D levels and risk of melanoma in larger, more diverse study populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, one large study found no association between serum vitamin D levels and melanoma risk141.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266
Melanoma and sun exposure: An overview of published studies
Elwood, J. M., & Jopson, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r · Cited by 791 · cited 1×
“The primary etiologic factor for melanoma is solar ultraviolet (UV) radiation exposure [3–5], but interest in the potential role of circulating high vitamin D concentrations has increased owing in part to recently observed associations with reduced melanoma tumor progression and improved survival [6–8].”
BackgroundCOLSTON, K., COLSTON, M. J., & FELDMAN, D. (1981) · Endocrinology · doi:10.1210/endo-108-3-1083 · Cited by 558 · cited 1×
“In human melanoma cell lines, in vitro studies indicate 1,25(OH)D inhibits cell growth [14,15].”
Background(1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90036-1 · Cited by 524
Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., Mullie, P., & Autier, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25439 · Cited by 499 · cited 1×
“Vitamin D status is contributed to by ultraviolet B (UVB) exposure from sunlight and by diet and supplements [9,10].”
BackgroundTuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11375 · Cited by 428 · cited 2×
“Although previous prospective studies have not examined risk of developing melanoma, associations between serum vitamin D level and cancer risk have been reported, with a potential U-shaped association suggested for prostate and pancreatic cancer [11,21].”
BackgroundResultThe Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure
Østerlind, A., Tucker, M. A., Stone, B. J., & Jensen, O. M. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420303 · Cited by 357 · cited 1×
“The primary etiologic factor for melanoma is solar ultraviolet (UV) radiation exposure [3–5], but interest in the potential role of circulating high vitamin D concentrations has increased owing in part to recently observed associations with reduced melanoma tumor progression and improved survival [6–8].”
BackgroundJorde, R., Sneve, M., Hutchinson, M., Emaus, N., Figenschau, Y., & Grimnes, G. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq005 · Cited by 315 · cited 1×
“We only had a single measure of serum 25(OH)D, however, which may not reflect long-term exposure and did not allow us to examine changes in vitamin D concentration levels over time although moderate correlations between measures collected years apart have been reported elsewhere [26,27].”
BackgroundNewton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295 · cited 1×
“The primary etiologic factor for melanoma is solar ultraviolet (UV) radiation exposure [3–5], but interest in the potential role of circulating high vitamin D concentrations has increased owing in part to recently observed associations with reduced melanoma tumor progression and improved survival [6–8].”
BackgroundDiet and Melanoma in a Case-Control Study
Millen, A. E., Tucker, M. A., Hartge, P., Halpern, A., Elder, D. E., Guerry, D., Holly, E. A., Sagebiel, R. W., & Potischman, N. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1042.13.6 · Cited by 172
Vitamin D and Cancer Incidence in the Harvard Cohorts
Giovannucci, E. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.12.002 · Cited by 163 · cited 1×
“Circulating levels of 25(OH)D serves as a marker of vitamin D status based on its accessibility and precursor function to hormonal form, 1,25(OH)D [12,13].”
BackgroundRanderson-Moor, J. A., Taylor, J. C., Elliott, F., Chang, Y.-M., Beswick, S., Kukalizch, K., Affleck, P., Leake, S., Haynes, S., Karpavicius, B., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.011 · Cited by 147 · cited 1×
“The primary etiologic factor for melanoma is solar ultraviolet (UV) radiation exposure [3–5], but interest in the potential role of circulating high vitamin D concentrations has increased owing in part to recently observed associations with reduced melanoma tumor progression and improved survival [6–8].”
BackgroundHofmann, J. N., Yu, K. F., Horst, R. L., Hayes, R. B., & Purdue, M. P. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1121 · Cited by 134
Self-citationTang, J. Y., Fu, T., LeBlanc, E., Manson, J. E., Feldman, D., Linos, E., Vitolins, M. Z., Zeitouni, N. C., Larson, J., & Stefanick, M. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.5967 · Cited by 117 · cited 1×
“Reports from population-based studies examining higher dietary or supplemental intake of vitamin D have been inconsistent; some showing a reduced risk of melanoma overall [22,23] and some showing no association [24,25].”
BackgroundStolzenberg-Solomon, R. Z., Hayes, R. B., Horst, R. L., Anderson, K. E., Hollis, B. W., & Silverman, D. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2694 · Cited by 109 · cited 1×
“Although previous prospective studies have not examined risk of developing melanoma, associations between serum vitamin D level and cancer risk have been reported, with a potential U-shaped association suggested for prostate and pancreatic cancer [11,21].”
ResultSelf-citationReduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.
Nürnberg, B., Gräber, S., Gärtner, B. C., Geisel, J., Pföhler, C., Schadendorf, D., Tilgen, W., & Reichrath, J. (2009) · PubMed · Cited by 108
Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer
Tworoger, S. S., Lee, I.-M. M., Buring, J. E., ROSNER, B. A., Hollis, B. W., & Hankinson, S. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0981 · Cited by 102 · cited 1×
“Circulating levels of 25(OH)D serves as a marker of vitamin D status based on its accessibility and precursor function to hormonal form, 1,25(OH)D [12,13].”
Backgroundfor the Osteoporotic Fractures in Men (MrOS) Study Group, Tang, J. Y., Parimi, N., Wu, A., John Boscardin, W., Shikany, J. M., Chren, M.-M., Cummings, S. R., Epstein, E. H., & Bauer, D. C. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9470-4 · Cited by 99 · cited 1×
“A previous population study examining vitamin D and nonmelanoma skin cancer (NMSC) showed high serum 25(OH)D levels related to decreased risk of NMSC [19], while a case study of 14 melanoma patients found 25(OH)D serum levels ranged from 50 to 125 nmol/L, not supporting the hypothesis that deficient levels are associa…”
BackgroundEvans, S. R. T., Houghton, A. M., Schumaker, L., Brenner, R. V., Buras, R. R., Davoodi, F., Nauta, R. J., & Shabahang, M. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0092 · Cited by 90 · cited 1×
“In human melanoma cell lines, in vitro studies indicate 1,25(OH)D inhibits cell growth [14,15].”
BackgroundWeinstock, M. A., Stampfer, M. J., Lew, R. A., Willett, W. C., & Sober, A. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499962 · Cited by 78
Gallicchio, L. M., Helzlsouer, K. J., Chow, W., Freedman, D. M., Hankinson, S. E., Hartge, P. A., Hartmuller, V. W., Harvey, C., Hayes, R. B., Horst, R. L., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq116 · Cited by 77
Self-citationVinceti, M., Malagoli, C., Fiorentini, C., Longo, C., Crespi, C. M., Albertini, G., Ricci, C., Lanzoni, A., Reggiani, M., Virgili, A., et al. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.539314 · Cited by 52 · cited 1×
“Reports from population-based studies examining higher dietary or supplemental intake of vitamin D have been inconsistent; some showing a reduced risk of melanoma overall [22,23] and some showing no association [24,25].”
BackgroundGRUBER, S. B., & ARMSTRONG, B. K. (2006) · Cancer Epidemiology and Prevention · doi:10.1093/acprof:oso/9780195149616.003.0063 · Cited by 52 · cited 1×
“Skin cancer is the most common cancer in the United States, with malignant melanoma being the most lethal and clinically invasive form resulting from transformation of melanocytes in skin (ocular and intestinal primaries also occur) [1].”
BackgroundNo evidence for reduced 25-hydroxyvitamin D serum levels in melanoma patients
Reichrath, J., & Querings, K. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000016676.23024.e8 · Cited by 21 · cited 1×
“A previous population study examining vitamin D and nonmelanoma skin cancer (NMSC) showed high serum 25(OH)D levels related to decreased risk of NMSC [19], while a case study of 14 melanoma patients found 25(OH)D serum levels ranged from 50 to 125 nmol/L, not supporting the hypothesis that deficient levels are associa…”
BackgroundHutchinson, P. E., Osborne, J. E., & Pringle, J. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.6095 · Cited by 16 · cited 1×
“Case-control studies have found associations with improved prognosis, but no association between 25(OH)D and disease status based on post-diagnostic blood samples [6,16].”
Background
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Review of Natural Compounds for Potential Skin Cancer Treatment
Chinembiri, T., Du Plessis, L., Gerber, M., Hamman, J., & Du Plessis, J. (2014) · Molecules · doi:10.3390/molecules190811679 · Cited by 270
“Epidemiological studies have shown no relationship between vitamin D intake, nor pre-diagnostic vitamin D serum levels and a susceptibility to develop melanoma [145,146].”
BackgroundSocioeconomic and lifestyle factors and melanoma: a systematic review
Jiang, A. J., Rambhatla, P. V., & Eide, M. J. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13500 · Cited by 164
Lucas, R. M., Norval, M., Neale, R. E., Young, A. R., de Gruijl, F. R., Takizawa, Y., & van der Leun, J. C. (2014) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp90033b · Cited by 158
“…281,282 and adverse 283 associations between concentrations of 25(OH)D and risk of NMSC and similar inconsistencies for the risk of CMM. 283,284 Post-hoc analyses of the Women ’ s Health Initiative trial did not show a protective e ff ect of supplementation with vitamin D on the risk of…”
Caini, S., Boniol, M., Tosti, G., Magi, S., Medri, M., Stanganelli, I., Palli, D., Assedi, M., del Mármol, V., & Gandini, S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.024 · Cited by 134
“Four studies [28,38–40] (392 CM cases overall) reported measures of melanoma risk across categories of increasing 25(OH)D serum levels: these were metaanalysed to yield a non-significant SRR of 1.”
BackgroundMethodResultInfluential
Metadata
- Authors
- Major, J. M., Kiruthu, C., Weinstein, S. J., Horst, R. L., Snyder, K., Virtamo, J., & Albanes, D.
- Affiliations
- National Institutes of Health (US)
- Information Management Services (US)
- Finnish Institute for Health and Welfare (FI)
- Corresponding author
- Major, Jacqueline M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-25
- Volume
- 7
- Issue
- 4
- Pages
- e35112
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3338826
- OpenAlex
- W2039207975
- Cited by
- 35
- References
- 27
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 2
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- WOS
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (N01-RC- 45035, N01RC37004, n01rc37004-9-0-0, HHSN261201000006C, n01cn045165-030, N01 RC037004, N01-CN-45165)
- National Cancer Institute (HHSN261201000006C, N01 CN045165, N01 CN 45165)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- vitamin D, 25-hydroxyvitamin D, melanoma, melanoma risk, circulating biomarkers, pre-diagnostic biomarkers, men, smokers, seasonal variation
- MeSH terms
- Aged, Finland, Humans, Male, Melanoma, Middle Aged, Prospective Studies, Surveys and Questionnaires, Skin Neoplasms, Smoking, Vitamin D, Logistic Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.